These emerging treatments, Tirzepatide , represent a remarkable advancement in managing obesity and possibly related ailments . They all are categorized as GLP-1 hormone stimulators, signifying they to replicate the body's GLP-1 substance , enhancing glucose secretion and lowering hunger . Although Semaglutide each one operates somewhat similarly,